HIV and multidrug-resistant tuberculosis: overlapping epidemics

Dean Anna S., Zignol Matteo, Falzon Dennis, Getahun Haileyesus, Floyd Katherine

Source: Eur Respir J 2014; 44: 251-254
Journal Issue: July
Disease area: Respiratory infections

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Dean Anna S., Zignol Matteo, Falzon Dennis, Getahun Haileyesus, Floyd Katherine. HIV and multidrug-resistant tuberculosis: overlapping epidemics. Eur Respir J 2014; 44: 251-254

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Multidrug-resistant tuberculosis and HIV infection in Eastern Europe: Two overlapping epidemics
Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview
Year: 2012

Multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in Romania
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011


HIV and multidrug-resistant tuberculosis: overlapping risk factors
Source: Eur Respir J 2015; 45: 567-569
Year: 2015


Multidrug-resistant tuberculosis: eight years of surveillance in France
Source: Eur Respir J 2003; 22: 833-837
Year: 2003



Multidrug-resistant TB in children with HIV infection
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city
Source: Eur Respir J 2013; 41: 901-908
Year: 2013



Extensively drug-resistant (XDR) pulmonary tuberculosis in HIV negative cases
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008

Multidrug-resistant TB in children with HIV infection in Romania
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011


Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
Source: Eur Respir J 2012; 39: 1425-1431
Year: 2012



TB in migrants
Source: Eur Respir Mon 2012; 58: 194-205
Year: 2012


Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection.
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018

The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine.
Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people
Year: 2018

On tuberculosis and COVID-19 co-infection
Source: Eur Respir J, 56 (2) 2002328; 10.1183/13993003.02328-2020
Year: 2020



Analysis of multidrug-resistant tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Epidemiology of TB
Source: Eur Respir Mon 2012; 58: 14-25
Year: 2012


Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden
Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces
Year: 2016


Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
Source: Eur Respir J 2015; 46: 1563-1576
Year: 2015



Treatment of TB
Source: Eur Respir Mon 2012; 58: 154-166
Year: 2012


Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
Source: Eur Respir J, 55 (6) 1902383; 10.1183/13993003.02383-2019
Year: 2020